Andrew Brenner

8.9k citations
194 papers · 5.1k indexed · 2 hit papers · h-index 39

Impact in

    • MicroRNA in disease regulation
    • Cancer, Hypoxia, and Metabolism
    • Cancer-related molecular mechanisms research
  • Genetics top 2%
    • Glioma Diagnosis and Treatment

Papers in

Andrew Brenner

186 papers receiving 5.0k citations

Hit Papers

First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors 2021 · 192 citations
1922016202620192022200400600

Peers

Andrew Brenner
Comparison fields: 5 of 154
  • Cancer Research 1.6k
  • Genetics 581
  • Oncology 1.1k
  • Molecular Biology 2.5k
  • Global and Planetary Change 459
Replace Antonella De Angelis with:
Antonella De Angelis Italy
Yanping Guo China
Xiaodong Huang China
Bruno Clément France
Jean‐Charles Nault France
Bruno Coudert France
Ping Yue China
Paul C. McDonald Canada
Bixiang Zhang China
Patricia Müller United Kingdom
Andrew Brenner relative to Antonella De Angelis Italy Antonella De Angelis's profile →
Citations per field
00.5×4.9×
Antonella De Angelis · 1×
Citations per year

Countries citing papers authored by Andrew Brenner

Since Specialization
Citations

This map shows the geographic impact of Andrew Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Brenner more than expected).

Fields of papers citing papers by Andrew Brenner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Brenner. The network helps show where Andrew Brenner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew Brenner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Brenner Line = papers co-authored together Andrew Brenner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 202412
3 20246
4 20243
5 20231
6 20238
7 20234
8 202374
9 20231
10 202117
11 202135
12 2020178
13 2019187
14 201919
15 20167
16 20159
17 201282
18 201021
19
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
199650
20 19915

About Andrew Brenner

Andrew Brenner is a scholar working on Genetics, Structural Biology, Cancer Research, Biotechnology and Oncology, having authored 194 papers that have together received 5.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (57 papers), Cancer, Hypoxia, and Metabolism (28 papers), Radiopharmaceutical Chemistry and Applications (23 papers), Cancer, Lipids, and Metabolism (23 papers), Cancer Research and Treatments (16 papers), Brain Metastases and Treatment (14 papers), Cancer Treatment and Pharmacology (14 papers) and Estrogen and related hormone effects (13 papers). The work is most often cited by research in Cancer Research (1.6k citations), Genetics (581 citations), Oncology (1.1k citations), Molecular Biology (2.5k citations) and Global and Planetary Change (459 citations). Andrew Brenner has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include C. Marcelo Aldaz, Edward D. Harris, Martha R. Stampfer, Jay Stoudemire, David S. Hong, Sinil Kim, Stephen M. Smith, Mitesh J. Borad, Jasgit C. Sachdev and Andreas G. Bader. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Cancer Research, Neuro-Oncology Advances and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026